138 related articles for article (PubMed ID: 19887833)
1. Is cystatin C a useful marker in the detection of diabetic kidney disease?
Borges RL; Hirota AH; Quinto BM; Ribeiro AB; Zanella MT; Batista MC
Nephron Clin Pract; 2010; 114(2):c127-34. PubMed ID: 19887833
[TBL] [Abstract][Full Text] [Related]
2. Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes.
Rigalleau V; Beauvieux MC; Le Moigne F; Lasseur C; Chauveau P; Raffaitin C; Perlemoine C; Barthe N; Combe C; Gin H
Diabetes Metab; 2008 Nov; 34(5):482-9. PubMed ID: 18703370
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cystatin C- and creatinine-based estimation of glomerular filtration rate according to glycaemic status in Type 2 diabetes.
Oh SJ; Lee JI; Ha WC; Jeong SH; Yim HW; Son HS; Sohn TS
Diabet Med; 2012 Jul; 29(7):e121-5. PubMed ID: 22414167
[TBL] [Abstract][Full Text] [Related]
4. The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes.
Macisaac RJ; Tsalamandris C; Thomas MC; Premaratne E; Panagiotopoulos S; Smith TJ; Poon A; Jenkins MA; Ratnaike SI; Power DA; Jerums G
Diabet Med; 2007 Apr; 24(4):443-8. PubMed ID: 17388960
[TBL] [Abstract][Full Text] [Related]
5. Serum cystatin C-based formulas for prediction of glomerular filtration rate in patients with chronic kidney disease.
Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
Nephron Clin Pract; 2010; 114(2):c118-26. PubMed ID: 19887832
[TBL] [Abstract][Full Text] [Related]
6. The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy.
Lee BW; Ihm SH; Choi MG; Yoo HJ
Diabetes Res Clin Pract; 2007 Dec; 78(3):428-34. PubMed ID: 17822797
[TBL] [Abstract][Full Text] [Related]
7. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
[TBL] [Abstract][Full Text] [Related]
8. Cystatin C and blood pressure: results of 24 h ambulatory blood pressure monitoring.
Mena C; Robles NR; de Prado JM; Gallego FG; Cidoncha A
Eur J Intern Med; 2010 Jun; 21(3):185-90. PubMed ID: 20493420
[TBL] [Abstract][Full Text] [Related]
9. [If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?].
Peczyńska J; Urban M; Głowińska B; Florys B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):141-6. PubMed ID: 16232367
[TBL] [Abstract][Full Text] [Related]
10. Are prediction equations for glomerular filtration rate useful for the long-term monitoring of type 2 diabetic patients?
Fontseré N; Salinas I; Bonal J; Bayés B; Riba J; Torres F; Rios J; Sanmartí A; Romero R
Nephrol Dial Transplant; 2006 Aug; 21(8):2152-8. PubMed ID: 16702203
[TBL] [Abstract][Full Text] [Related]
11. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
Malyszko J; Bachorzewska-Gajewska H; Sitniewska E; Malyszko JS; Poniatowski B; Dobrzycki S
Ren Fail; 2008; 30(6):625-8. PubMed ID: 18661413
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C as a marker of renal function is affected by HIV replication leading to an underestimation of kidney function in HIV patients.
Mauss S; Berger F; Kuschak D; Henke J; Hegener P; Wolf E; Schauseil S; Schmutz G
Antivir Ther; 2008; 13(8):1091-5. PubMed ID: 19195336
[TBL] [Abstract][Full Text] [Related]
13. New predictive equations improve monitoring of kidney function in patients with diabetes.
Beauvieux MC; Le Moigne F; Lasseur C; Raffaitin C; Perlemoine C; Barthe N; Chauveau P; Combe C; Gin H; Rigalleau V
Diabetes Care; 2007 Aug; 30(8):1988-94. PubMed ID: 17536079
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of serum cystatin C in Japanese patients with type 2 diabetes mellitus and nephropathy.
Kimura T; Ikeda H; Fujikawa J; Nomura K; Aoyama T; Wada Y; Nabe K; Hamamoto Y; Honjo S; Koshiyama H
Diabetes Res Clin Pract; 2009 Feb; 83(2):e58-61. PubMed ID: 19118914
[TBL] [Abstract][Full Text] [Related]
15. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis.
Sato H; Kuroda T; Tanabe N; Ajiro J; Wada Y; Murakami S; Sakatsume M; Nakano M; Gejyo F
Scand J Rheumatol; 2010; 39(1):33-7. PubMed ID: 20132068
[TBL] [Abstract][Full Text] [Related]
16. Cystatin C does not detect acute changes in glomerular filtration rate in early diabetic nephropathy.
Mueller TF; Raeder J; Oettl K; Zitta S; Klausmann G; Estelberger W; Luyckx VA; Reibnegger G
Ren Fail; 2008; 30(1):21-9. PubMed ID: 18197539
[TBL] [Abstract][Full Text] [Related]
17. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate.
Hoek FJ; Kemperman FA; Krediet RT
Nephrol Dial Transplant; 2003 Oct; 18(10):2024-31. PubMed ID: 13679476
[TBL] [Abstract][Full Text] [Related]
18. Cystatin C in acute heart failure without advanced renal impairment.
Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
[TBL] [Abstract][Full Text] [Related]
19. The inaccuracy of cystatin C and creatinine-based equations in predicting GFR in orthotopic liver transplant recipients.
Boudville N; Salama M; Jeffrey GP; Ferrari P
Nephrol Dial Transplant; 2009 Sep; 24(9):2926-30. PubMed ID: 19506046
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients.
Lee SH; Park SA; Ko SH; Yim HW; Ahn YB; Yoon KH; Cha BY; Son HY; Kwon HS
Metabolism; 2010 Feb; 59(2):241-6. PubMed ID: 19765773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
